| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Articles |
Isala Klinieken Zwolle, Departments of Pediatrics (E.L.T.v.d.A.), Internal Medicine (A.A.M.F.), Clinical Chemistry (A.P.A., H.E.), 8025 AB Zwolle, The Netherlands; and Rudolf Magnus Institute for Neurosciences, Department of Medical Pharmacology, Utrecht University (M.N., R.Z., D.d.W., J.P.H.B.), 3508 TA Utrecht, The Netherlands
Address all correspondence and requests for reprints to: Dr. J. Peter H. Burbach, Rudolf Magnus Institute for Neurosciences, Utrecht University, P.O. Box 80040, 3508 TA Utrecht, The Netherlands. E-mail: j.p.h.burbach{at}med.uu.nl
Abstract
Familial neurohypophysial diabetes insipidus (FNDI) is an autosomal
dominant trait in which expression of a mutant vasopressin prohormone
reduces vasopressin production. We investigated the NP85 Cys
Gly
mutant vasopressin prohormone in a large kindred in The Netherlands. We
demonstrate that growth retardation is an important early sign in two
children from this kindred, which recuperates by substitution therapy
with 1-desamino-8-D-arginine
vasopressin. To obtain clues about the basis for the
dominant inheritance of FNDI, we analyzed the trafficking and
processing of the mutant vasopressin prohormone in cell lines by
metabolic labeling and immunoprecipitation. The mutant vasopressin
prohormone was retained in the endoplasmic reticulum and thus was not
processed to vasopressin. This defect was not caused by dimerization of
the vasopressin prohormone via its unpaired cysteine residue. High
level expression of the mutant vasopressin prohormone in cell lines
resulted in strong accumulation in the endoplasmic reticulum and an
altered morphology of this organelle. We hypothesize that disturbance
of the endoplasmic reticulum results in dysfunction and ultimately cell
death of the cells expressing the mutant prohormone. Our data support
the hypothesis that FNDI is a progressive neurodegenerative disease
with delayed onset of symptoms. Its treatment requires early detection
of symptoms for which growth parameters are useful.
This article has been cited by other articles:
![]() |
M. Hayashi, H. Arima, N. Ozaki, Y. Morishita, M. Hiroi, N. Ozaki, H. Nagasaki, N. Kinoshita, M. Ueda, A. Shiota, et al. Progressive polyuria without vasopressin neuron loss in a mouse model for familial neurohypophysial diabetes insipidus Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2009; 296(5): R1641 - R1649. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Christensen, C. Siggaard, T. J. Corydon, G. L. Robertson, N. Gregersen, L. Bolund, and S. Rittig Differential Cellular Handling of Defective Arginine Vasopressin (AVP) Prohormones in Cells Expressing Mutations of the AVP Gene Associated with Autosomal Dominant and Recessive Familial Neurohypophyseal Diabetes Insipidus J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4521 - 4531. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Wahlstrom, M. J. Fowler, W. E. Nicholson, and W. J. Kovacs A Novel Mutation in the Preprovasopressin Gene Identified in a Kindred with Autosomal Dominant Neurohypophyseal Diabetes Insipidus J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1963 - 1968. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rittig, C. Siggaard, M. Ozata, I. Yetkin, N. Gregersen, E. B. Pedersen, and G. L. Robertson Autosomal Dominant Neurohypophyseal Diabetes Insipidus due to Substitution of Histidine for Tyrosine2 in the Vasopressin Moiety of the Hormone Precursor J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3351 - 3355. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |